Alginate-encapsulated human hepatoblastoma cells in an extracorporeal perfusion system improve some systemic parameters of liver failure in a xenogeneic model

Artificial Organs

Volumn 28, Issue 5, 2004, Pages 476-482

  Rahman, Tony M ^a   Seiden, Clare ^a   Khalil, Marianne ^a   Diakanov, Ivan ^a   Hodgson, Humphrey J F ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Bioartificial liver; Encapsulation; HepG2 cells; Liver failure; Plasmapheresis

Indexed keywords

ARTIFICIAL ORGANS; BLOOD PRESSURE; CELLS; ENCAPSULATION; ENZYME ACTIVITY;

ACUTE LIVER FAILURE; ALGINATE ENCAPSULATION; BIOARTIFICIAL LIVER; CELL LINES; HEP-G2 CELLS; HEPATOCYTE FUNCTIONS; HEPATOCYTES; LIVER FAILURE; PERFUSION SYSTEM; PLASMAPHERESIS;

CELL CULTURE;

ALGINIC ACID; CYTOCHROME P450; PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ENCAPSULATION; CELL STRAIN HEPG2; CELL TRANSPLANTATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; ENZYME ACTIVITY; EXPERIMENTAL MODEL; EXTRACORPOREAL CIRCULATION; HEPATOBLASTOMA; LIVER FAILURE; LIVER PERFUSION; MALE; NONHUMAN; OXYGEN SATURATION; PARAMETER; PREMEDICATION; PRIORITY JOURNAL; RABBIT; VENOUS OXYGEN TENSION; XENOGRAFT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 2542440939     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2004.07259.x     Document Type: Article

References (23)

1. Mitry RR, Hughes RD, Dhawan A. Progress in human hepatocytes; isolation, culture & cryopreservation. Semin Cell Dev Biol 2002;13:463-7.
2. Runge D, Michaelopoulos GK, Strom SC, Runge DM. Recent advances in human hepatocyte cultlure systems. Biochem Biophys Res Commun 2000;21:274.
3. Sechser A, Osorio J, Freise C, Osorio RW. Artificial liver support devices for fulminant liver failure. Clin Liver Dis 2001;5:415-30.
4. Watanabe FD, Mullon CJ, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg 1997;225:484-91.
5. Hui T, Rozga J, Demetriou AA. Bioartificial liver support. J Hepatobiliary Pancreat Surg 2001;8:1-15.
6. Kelly JH, Koussayer T, He D, Chong MG, Shang TA, Whisennand HH, Sussman NL. Assessment of an extracorporeal liver assist device in anhepatic dogs. Artif Organs 1992;16:418-22.
7. Smalley M, Leiper K, Floyd D, et al. Behavior of a cell line derived from normal human hepatocytes on non-physiological and physiological-type substrates: evidence for enhancement of secretion of liver-specific proteins by a three-dimensional growth pattern. In Vitro Cell Dev Biol Anim 1999;35:22-32.
8. Ellis AJ, Hughes RD, Wendon JA, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996;24:1446-51.
9. Khalil M, Shariat-Panahi A, Tootle R, et al. Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function. J Hepatol 2001;34:68-77.
10. Selden C, Khalil M, Hodgson H. Three dimensional culture upregulates extracellular matrix protein expression in human liver cell lines - a step towards mimicking the liver in vivo? Int J Artif Organs 2000;23:774-81.
11. Selden C, Shariat A, McCloskey P, Ryder T, Roberts E, Hodgson H. Three-dimensional in vitro cell culture leads to a marked upregulation of cell function in human hepatocyte cell lines - an important tool for the development of a bioartificial liver machine. Ann N Y Acad Sci 1999;875:353-63.
12. Rahman TM, Selden AC, Hodgson HJ. A novel model of acetaminophen-induced acute hepatic failure in rabbits. J Surg Res 2002;106:264-72.
13. Baquerizo A, Mhoyan A, Kearns-Jonker N, et al. Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment; an ex vivo model of pig to human xenotransplantation. Transplantation 1999;67:5-18.
14. Dorling A. Clinical xenotransplantation: pigs might fly? Am J Transplant 2002;2:695-700.
15. Clemenceau B, Jegou D, Martignat L, Sai P. Microchimerism and transmission of porcine endogenous retrovirus from a pig cell line or specific pathogen-free pig islets to mouse tissues and human cells during xenografts in nude mice. Diabetologia 2002;45:914-23.
16. Terblanche J, Hickman R. Animal models of fulminant hepatic failure. Dig Dis Sci 1991;36:770-4.
17. Ellis A, Wendon J. Circulatory, respiratory, cerebral and renal derangements in acute liver failure, pathophysiology and management. Semin Liver Dis 1996;16:379-88.
18. Hazell A, Butterworth R. Hepatic encephalopathy: an update of pathophysiologic mechanisms. Proc Soc Exp Biol Medical 1999;222:99-112.
19. Enosawa S, Miyashita T, Fujita Y, et al. In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure. Cell Transplant 2001;10:429-33.
20. Enosawa S, Miyashita T, Tanaka H, et al. Prolongation of survival of pigs with ischemic liver failure by treatment with a bioartificial liver using glutamine synthetase transfected recombinant HepG2. Transplant Proc 2001;33:1945-7.
21. Doodstdar H, Grant MH, Melvin WT, Wolf CR, Burke MD. The effects of inducing agents on cytochrome P450 and UDP-glucuronyltransferaseactivities in human HEPG2 hepatoma cells. Biochem Pharmacol 1993;46:629-35.
22. Ali MA, Billing BH. Renal excretion of bilirubin by the rat. Am J Physiol 1968;214:1340-5.
23. Gollan JL, Dallinger KJ, Billing BH. Excretion of conjugated bilirubin in the isolated perfused rat kidney. Clin Sci Mol Med 1978;54:381-9.